Development of stem cell-based gene therapies, wherein MSCs are genetically engineered to express therapeutic molecules and therefore, act as targeted delivery vehicles to enhance our ability to treat metastatic cancers. To this end, a number of therapeutic molecules have been investigated, including direct effectors of apoptosis.